z-logo
open-access-imgOpen Access
MP83-20 AN ASSESSMENT OF IMMUNE CHECKPOINT EXPRESSION AMONG PATIENTS WITH NMIBC UNDERGOING INTRAVESICAL BCG: IMPLICATIONS FOR ONGOING RANDOMIZED TRIALS.
Author(s) -
Max Kates,
Andrés Matoso,
Alex S. Baras,
Aaron Brant,
Noah M. Hahn,
David J. McConkey,
Charles G. Drake,
Trinity J. Bivalacqua
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.2768
Subject(s) - medicine , immunotherapy , bladder cancer , immune system , immune checkpoint , oncology , cancer , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom